Human interleukin 3: effects on normal and leukemic cells

Area of Science:

• Hematology
• Cell Biology
• Immunology

Background:

• Interleukin 3 (IL3) is a key cytokine involved in hematopoiesis.
• Understanding IL3's role in normal and malignant hematopoiesis is crucial for therapeutic development.

Purpose of the Study:

• To investigate the effects of recombinant human IL3 on normal bone marrow cells and various human leukemic cell lines.
• To determine if leukemic cells produce IL3, potentially contributing to their proliferation.

Main Methods:

• Clonal assays were used to assess IL3's effect on bone marrow cell colony formation.
• Replating experiments evaluated the sustained proliferative capacity of IL3-stimulated progenitor cells.
• Flow cytometry and monoclonal antibody 3C5 were used for cell sorting.
• Analysis of IL3 mRNA transcripts in leukemic cells using RT-PCR or similar techniques.

Main Results:

• IL3 supported the growth of all normal bone marrow colony types, including megakaryocytes and mast cells.
• Erythroid colony formation required both IL3 and erythropoietin.
• IL3-induced proliferation of normal bone marrow cells was inhibited by tumor necrosis factor and lymphotoxin.
• Human IL3 had no discernible effect on the growth, morphology, or clonogenicity of tested human leukemic cell lines (HL60, U-937, KG1a, HEL).
• IL3 mRNA was not detected in these leukemic cell lines or K562 cells.
• Cells from patients with myeloproliferative disorders, myelodysplastic syndromes, or acute myeloid leukemia showed proliferative responses to IL3, but lacked IL3 mRNA.

Conclusions:

• Recombinant human IL3 is a potent stimulator of normal hematopoiesis.
• Human leukemic cell lines do not appear to rely on autocrine IL3 production for maintenance.
• The lack of IL3 mRNA in patient-derived leukemia cells suggests exogenous IL3 may influence these conditions, but autocrine production is not a factor.